Reuters logo
BRIEF-GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market
2017年7月12日 / 下午5点57分 / 4 个月前

BRIEF-GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market

July 12 (Reuters) - GE

* GE, global good licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market

* Agreement includes technology to create malaria serology tests for plasmodium antibodies which can measure population’s past exposure to disease​

* Agreement covers diagnostic test that identifies key proteins present in malaria, as well as PLDH RDT to detect malarial parasites Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below